Literature DB >> 31853819

The value of three-dimensional echocardiography in risk stratification in pulmonary arterial hypertension: a cross-sectional study.

Bing-Yang Liu1, Wei-Chun Wu2, Qi-Xian Zeng1, Zhi-Hong Liu1, Li-Li Niu2, Yue Tian2, Qin Luo1, Zhi-Hui Zhao1, Rui-Lin Quan1, Jing-Ru Lin2, Hao Wang2, Jian-Guo He1, Chang-Ming Xiong3.   

Abstract

To explore the value of right ventricular (RV) parameters detected by three-dimensional echocardiography (3DE) in risk stratification in pulmonary arterial hypertension (PAH) patients. We prospectively recruited 130 pulmonary hypertension patients from National Center for Cardiovascular Diseases, Fuwai Hospital. Each participant was performed a transthoracic echocardiography and 3DE parameters were measured using an off-line software (4D RV Function 2.0, TomTec). Patients were classified into low, intermediate-high risk group based on 2015 ESC Guidelines. A total of 91 PAH patients (34 ± 12 years old, 25 males) were enrolled, among which, 42 were classified into low risk group, while 49 were intermediate-high risk group. Compared with low-risk patients, those with intermediate-high risk had significantly larger 3DE-RV volumes, worse ejection fraction (EF) and tricuspid annular plane systolic excursion, and decreased longitudinal strain (LS). Receive operating characteristic curves illustrated all the 3DE parameters were able to predict intermediate-high risk stratification, especially 3D-RVEF (area under curve, 0.82, 95% CI 0.73-0.91, P < 0.001). And 3D-RVEF < 26.39% had a 81.6% sensibility and 73.8% specificity to predict intermediate-high risk stratification. Univariate and multivariate Logistic regression analyses identified 3D-RV end-diastolic (OR 1.02, 95% CI 1.01-1.03, P = 0.002) and end-systolic (OR 1.03, 95% CI 1.01-1.04, P < 0.001) volumes, 3D-RVEF (OR 0.82, 95% CI 0.75-0.90, P < 0.001) and LS of free wall (OR 1.17, 95% CI 1.05-1.31, P = 0.005) as independent predictors of intermediate-high risk stratification. In conclusion, RV volumes, EF and free wall strain detected by 3DE were independent predictors of intermediate-high risk stratification in PAH patients, among which, RVEF showed the best predictive capacity.

Entities:  

Keywords:  Disease severity; Pulmonary arterial hypertension; Right ventricular function; Risk stratification; Three-dimensional echocardiography

Mesh:

Year:  2019        PMID: 31853819     DOI: 10.1007/s10554-019-01743-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  23 in total

1.  Evaluation of right ventricular regional volume and systolic function in patients with pulmonary arterial hypertension using three-dimensional echocardiography.

Authors:  Dehong Kong; Xianhong Shu; Cuizhen Pan; Leilei Cheng; Lili Dong; Haohua Yao; Daxin Zhou
Journal:  Echocardiography       Date:  2012-04-11       Impact factor: 1.724

2.  Two-dimensional speckle tracking echocardiography assessed right ventricular function and exercise capacity in pre-capillary pulmonary hypertension.

Authors:  Bing-Yang Liu; Wei-Chun Wu; Qi-Xian Zeng; Zhi-Hong Liu; Li-Li Niu; Yue Tian; Xiao-Ling Cheng; Qin Luo; Zhi-Hui Zhao; Li Huang; Hao Wang; Jian-Guo He; Chang-Ming Xiong
Journal:  Int J Cardiovasc Imaging       Date:  2019-04-29       Impact factor: 2.357

3.  Characterization of right ventricular remodeling in pulmonary hypertension associated with patient outcomes by 3-dimensional wall motion tracking echocardiography.

Authors:  Keiko Ryo; Akiko Goda; Tetsuari Onishi; Antonia Delgado-Montero; Bhupendar Tayal; Hunter C Champion; Marc A Simon; Michael A Mathier; Mark T Gladwin; John Gorcsan
Journal:  Circ Cardiovasc Imaging       Date:  2015-06       Impact factor: 7.792

4.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

5.  Quantitative assessment of mitral inflow and aortic outflow stroke volumes by 3-dimensional real-time full-volume color flow doppler transthoracic echocardiography: an in vivo study.

Authors:  Eriko Shimada; Meihua Zhu; Sumito Kimura; Cole Streiff; Helene Houle; Saurabh Datta; David J Sahn; Muhammad Ashraf
Journal:  J Ultrasound Med       Date:  2015-01       Impact factor: 2.153

6.  A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.

Authors:  David Kylhammar; Barbro Kjellström; Clara Hjalmarsson; Kjell Jansson; Magnus Nisell; Stefan Söderberg; Gerhard Wikström; Göran Rådegran
Journal:  Eur Heart J       Date:  2018-12-14       Impact factor: 29.983

7.  Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology.

Authors:  Roberto Badagliacca; Roberto Poscia; Beatrice Pezzuto; Martina Nocioni; Mario Mezzapesa; Marco Francone; Elisa Giannetta; Silvia Papa; Cristina Gambardella; Susanna Sciomer; Maurizio Volterrani; Francesco Fedele; Carmine Dario Vizza
Journal:  J Heart Lung Transplant       Date:  2014-11-08       Impact factor: 10.247

8.  Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension.

Authors:  Benjamin C F Smith; Gary Dobson; David Dawson; Athanasios Charalampopoulos; Julia Grapsa; Petros Nihoyannopoulos
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

9.  Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension.

Authors:  Evan L Hardegree; Arun Sachdev; Hector R Villarraga; Robert P Frantz; Michael D McGoon; Sudhir S Kushwaha; Ju-Feng Hsiao; Robert B McCully; Jae K Oh; Patricia A Pellikka; Garvan C Kane
Journal:  Am J Cardiol       Date:  2012-10-23       Impact factor: 2.778

10.  Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension.

Authors:  Mitsushige Murata; Toshimitsu Tsugu; Takashi Kawakami; Masaharu Kataoka; Yugo Minakata; Jin Endo; Hikaru Tsuruta; Yuji Itabashi; Yuichiro Maekawa; Mitsuru Murata; Keiichi Fukuda
Journal:  Oncotarget       Date:  2016-12-27
View more
  1 in total

1.  The Role of Four-Dimensional Automatic Right Ventricular Quantification Technology to Determine RV Function and Hemodynamics in Patients With Pulmonary Hypertension Compared With Right Heart Catheterization.

Authors:  Weichun Wu; Bingyang Liu; Min Huang; David H Hsi; LiLi Niu; Yue Tian; Jingru Lin; Jiangtao Wang; Shuai Yang; Hongquan Lu; Changming Xiong; Zhenhui Zhu; Hao Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.